argenx SE (ARGX)
869.72
+44.11
(+5.34%)
USD |
NASDAQ |
Oct 20, 16:00
874.40
+4.68
(+0.54%)
After-Hours: 07:49
argenx Gross Profit (TTM) : 4.673B for June 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.673B |
| December 31, 2025 | 3.688B |
| June 30, 2025 | 2.723B |
| December 31, 2024 | 1.947B |
| June 30, 2024 | 1.334B |
| December 31, 2023 | 1.002B |
| June 30, 2023 | 631.61M |
| December 31, 2022 | 276.96M |
| June 30, 2022 | 88.82M |
| December 31, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Autolus Therapeutics Plc | 15.09M |
| Cellectis SA | 37.38M |
| Akari Therapeutics Plc | 0.00 |
| Forte Biosciences, Inc. | -0.075M |
| Halozyme Therapeutics, Inc. | 1.271B |